Skip to main content
Equibles
ATRC logo

ATRC · AtriCure, Inc. · Webcasts, Transcripts & Audio

Track ATRC — free

Use ATRC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATRC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$53.27 -0.32 (-0.60%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.93B
Shares
50.87M
Volume · Oct 1 1.97M Avg daily vol (3M) 1.08M

AtriCure, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for AtriCure, Inc. (ATRC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲18.1% $83.25M −$12.27M '22 Q3 22-11-01 ▲20.2% $88.03M −$4.17M '22 Q4 23-02-21 ▲25.4% $93.49M −$6.48M '23 Q1 23-05-02 ▲19.4% $100.92M −$5.12M '23 Q2 23-07-25 ▲18.1% $98.29M −$9.05M '23 Q3 23-11-01 ▲21% $106.54M −$9.79M '23 Q4 24-01-08 ▲16.4% $108.85M −$13.27M '24 Q1 24-05-01 ▲15.2% $116.27M −$8.01M '24 Q2 24-07-30 ▲17.9% $115.91M −$7.85M '24 Q3 24-10-29 ▲16.6% $124.28M −$15.57M '24 Q4 25-02-12 ▲13.6% $123.62M −$6.75M '25 Q1 25-04-29 ▲17.1% $136.14M −$6.19M '25 Q2 25-07-29 ▲15.8% $134.27M −$267,000 '25 Q3 25-10-29 ▲13.1% $140.50M $1.76M '25 Q4 26-02-17 ▲14.3% $141.25M $108,000 '26 Q1 26-05-05 LATEST ▲12.8% $153.60M $8.96M '26 Q2 26-07-23
Conference
Investor event
2026-09-08
AtriCure, Inc. (ATRC) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-11
AtriCure, Inc. (ATRC) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-23
AtriCure, Inc. (ATRC) Q2 2026 Earnings Call Transcript
Confident tone Appendage Management / AtriClip Pain Management Franchise Box No AF Clinical Trial
Revenue
$153.60M
▲ 12.8% YoY
Diluted EPS
$0.18
Gross margin
77.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-10
AtriCure, Inc. (ATRC) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript
Confident tone BoxX-NoAF Clinical Trial Pain Management / cryoSPHERE MAX Appendage Management / AtriClip FLEX-Mini & PRO-Mini
Revenue
$141.25M
▲ 14.3% YoY
Diluted EPS
$0.00
Gross margin
77.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript
Confident tone Financial Performance and Profitability Afib Ablation / Open Ablation LeAAPS Clinical Trial
Revenue
$140.50M*
▲ 13.1% YoY
Gross margin
75.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
AtriCure, Inc. (ATRC) Q3 2025 Earnings Call Transcript
Confident tone Appendage Management / AtriClip Growth Clinical Trials and Market Expansion Pain Management Franchise Growth
Revenue
$134.27M
▲ 15.8% YoY
Diluted EPS
$-0.01
Gross margin
75.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
AtriCure, Inc. (ATRC) Q2 2025 Earnings Call Transcript
Confident tone Appendage Management (AtriClip franchise) LeAAPS Clinical Trial Pain Management / Cryoablation
Revenue
$136.14M
▲ 17.1% YoY
Diluted EPS
$-0.13
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
AtriCure, Inc. (ATRC) Q1 2025 Earnings Call Transcript
Revenue
$123.62M
▲ 13.6% YoY
Diluted EPS
$-0.14
Gross margin
74.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-12
AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript
Confident tone Appendage Management / AtriClip Minimally Invasive / Hybrid AF Pressure from PFA Pain Management / Cryo Nerve Block
Revenue
$124.28M*
▲ 16.6% YoY
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-29
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript
Confident tone Hybrid AF Therapy / PFA Competition Appendage Management / AtriClip Pain Management Franchise
Revenue
$115.91M
▲ 17.9% YoY
Diluted EPS
$-0.17
Gross margin
74.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
AtriCure, Inc. (ATRC) Q2 2024 Earnings Call Transcript
Confident tone Pain management and CryoSPHERE AtriClip and appendage management Hybrid AF therapy and PFA impact
Revenue
$116.27M
▲ 15.2% YoY
Diluted EPS
$-0.17
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript
Confident tone AtriClip / Appendage management franchise Hybrid AF therapy and PFA complementarity Innovation and product launches
Revenue
$108.85M
▲ 16.4% YoY
Diluted EPS
$-0.28
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript
Confident tone Revenue growth and financial performance Appendage management (AtriClip) Hybrid AF therapy / CONVERGE
Revenue
$106.54M*
▲ 21% YoY
Gross margin
74.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
AtriCure, Inc. (ATRC) Q3 2023 Earnings Call Transcript
Revenue
$98.29M
▲ 18.1% YoY
Diluted EPS
$-0.20
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
AtriCure, Inc. (ATRC) Q2 2023 Earnings Call Transcript
Revenue
$100.92M
▲ 19.4% YoY
Diluted EPS
$-0.11
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
AtriCure, Inc. (ATRC) Q1 2023 Earnings Call Transcript
Revenue
$93.49M
▲ 25.4% YoY
Diluted EPS
$-0.14
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
AtriCure, Inc. (ATRC) Q4 2022 Earnings Call Transcript
Revenue
$88.03M*
▲ 20.2% YoY
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
AtriCure, Inc. (ATRC) Q3 2022 Earnings Call Transcript
Revenue
$83.25M
▲ 18.1% YoY
Diluted EPS
$-0.27
▼ 112.8% YoY
Gross margin
74.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
AtriCure, Inc. (ATRC) Q2 2022 Earnings Call Transcript
Revenue
$84.53M
▲ 18.4% YoY
Diluted EPS
$-0.32
Gross margin
75.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
AtriCure, Inc. (ATRC) Q1 2022 Earnings Call Transcript
Revenue
$74.58M
▲ 25.8% YoY
Diluted EPS
$-0.33
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
AtriCure, Inc. (ATRC) Q4 2021 Earnings Call Transcript
Revenue
$73.22M
▲ 26.8% YoY
Gross margin
75.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
AtriCure, Inc. (ATRC) Q3 2021 Earnings Call Transcript
Revenue
$70.46M
▲ 28.7% YoY
Diluted EPS
$2.11
Gross margin
74.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
AtriCure, Inc. (ATRC) Q2 2021 Earnings Call Transcript
Revenue
$71.38M
▲ 74.8% YoY
Diluted EPS
$-0.36
Gross margin
75.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
AtriCure, Inc. (ATRC) Q1 2021 Earnings Call Transcript
Revenue
$59.27M
▲ 11.4% YoY
Diluted EPS
$-0.38
Gross margin
75.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
AtriCure, Inc. (ATRC) Q4 2020 Earnings Call Transcript
Revenue
$57.73M
▼ 5.9% YoY
Gross margin
73.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
AtriCure, Inc. (ATRC) Q3 2020 Earnings Call Transcript
Revenue
$54.76M
▼ 3.3% YoY
Diluted EPS
$-0.11
Gross margin
73.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
AtriCure, Inc. (ATRC) Q2 2020 Earnings Call Transcript
Revenue
$40.82M
▼ 30.7% YoY
Gross margin
67.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
AtriCure, Inc. (ATRC) Q1 2020 Earnings Call Transcript
Revenue
$53.23M
▼ 1.4% YoY
Gross margin
73.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–29 of 29 webcasts
Key facts CIK 1323885 CUSIP 04963C209 13F (30d) 6 filings 6 filers Visit website Investor relations